IRIS
BONINI, Sergio
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 4.033
EU - Europa 4.024
AS - Asia 329
SA - Sud America 36
AF - Africa 12
Continente sconosciuto - Info sul continente non disponibili 10
OC - Oceania 5
Totale 8.449
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 4.023
IE - Irlanda 1.318
UA - Ucraina 981
GB - Regno Unito 620
DE - Germania 374
FI - Finlandia 248
SE - Svezia 191
GR - Grecia 150
TR - Turchia 148
CN - Cina 97
IT - Italia 81
IN - India 27
BE - Belgio 22
BR - Brasile 21
KR - Corea 13
ID - Indonesia 11
NL - Olanda 9
FR - Francia 8
EU - Europa 7
PK - Pakistan 7
CA - Canada 6
EC - Ecuador 6
DZ - Algeria 5
ES - Italia 5
JO - Giordania 5
JP - Giappone 5
SG - Singapore 5
CO - Colombia 4
AP - ???statistics.table.value.countryCode.AP??? 3
AR - Argentina 3
MX - Messico 3
NZ - Nuova Zelanda 3
RU - Federazione Russa 3
AU - Australia 2
BD - Bangladesh 2
IQ - Iraq 2
IR - Iran 2
LT - Lituania 2
LY - Libia 2
PL - Polonia 2
PT - Portogallo 2
RS - Serbia 2
TH - Thailandia 2
AE - Emirati Arabi Uniti 1
AT - Austria 1
BY - Bielorussia 1
CL - Cile 1
CZ - Repubblica Ceca 1
DK - Danimarca 1
EG - Egitto 1
GM - Gambi 1
MA - Marocco 1
MY - Malesia 1
NA - Namibia 1
NO - Norvegia 1
PA - Panama 1
PE - Perù 1
RO - Romania 1
SC - Seychelles 1
VN - Vietnam 1
Totale 8.449
Salva come PNG Salva come JPEG
Città #
Jacksonville 1.463
Dublin 1.317
Chandler 552
Princeton 245
Medford 233
San Mateo 167
Boardman 160
Wilmington 115
Ann Arbor 89
Woodbridge 66
Roxbury 56
Cambridge 54
Des Moines 36
Ashburn 29
Beijing 20
New York 18
Redwood City 18
Mountain View 17
Nanjing 16
Brussels 15
Düsseldorf 15
Pune 12
Houston 11
Jinan 11
Norwalk 11
Rome 9
Kunming 8
São Paulo 8
Fairfield 7
Auburn Hills 6
London 6
Los Angeles 6
Tianjin 6
Bremen 5
Città di Castello 5
Haikou 5
Nanchang 5
Orange 5
Quito 5
Seattle 5
Shanghai 5
Groningen 4
Hebei 4
L'aquila 4
Longueville 4
Pakistan 4
Arzano 3
Brantford 3
Duncan 3
Helsinki 3
Patras 3
Santa Clara 3
Seoul 3
Taiyuan 3
Venice 3
Belgrade 2
Berlin 2
Bogotá 2
Capannelle 2
Caserta 2
Champaign 2
Changsha 2
Dhaka 2
Flensburg 2
Ghent 2
Hangzhou 2
Hanover 2
Jūnāgadh 2
Lahore 2
Lanzhou 2
Madrid 2
Melbourne 2
Milan 2
Missaglia 2
Munro 2
Patna 2
Pavia 2
Saint Ives 2
Shenyang 2
Stony Brook 2
Toronto 2
Vanzaghello 2
Adana 1
Amsterdam 1
Andover 1
Appiano Gentile 1
Avellino 1
Bandung 1
Bangkok 1
Berkeley 1
Bydgoszcz 1
Centrale 1
Cesenatico 1
Changchun 1
Changshahsien 1
Collegeville 1
Copenhagen 1
Denpasar 1
Denver 1
Dubai 1
Totale 4.961
Salva come PNG Salva come JPEG
Nome #
Global Allergy and Asthma European Network: Grading of Recommendations Assessment, Development and Evaluation Working Group: Allewrgic Rhinitis and its Impact on Asthma (ARIA) Guidelines: 2010 revision 167
Allergic Rhinitis and its Impact on Asthma (ARIA): In collaboration with the World Health Organization 112
A case-control study of the relation between plasma selenium and asthma in European populations: a GAL2EN project 63
GA(2)LEN (Global Allergy and Asthma European Network): European network of excellence for asthma and allergic diseases 59
The genetics of atopy 59
POLLENOSIS 2000. GLOBAL APPROACH 59
Uso del Fattore di crescita nervoso (NGF)per l'espansione in vitro di cellule staminali del cordone ombelicale 57
Uso dei probiotici nella prevenzione e nel trattamento delle congiuntiviti allergiche 56
The additional values of microarray allergen assay in the management of polysensitized patients with respiratory allergy 54
Methodology for development of the Allergic Rhinitis and its Impact on Asthma guideline 2008 update 54
Epidemiology of allergic occupational diseases induced by Tetranychus urticae in greenhouse and open-field farmers living in a temperate climate area 54
A multicentric study on sensitivity and specificity of a new in vitro test for measurement of IgE antibodies 54
GA2LEN (GLOBAL ALLERGY AND ASTHMA EUROPEAN NETWORK) ADDRESSES THE ALLERGY AND ASTHMA 'EPIDEMIC' 53
Allergic Rhinitis and its Impact on Asthma (ARIA) 2008 update (in collaboration with the World Health Organization, GA(2)LEN and AllerGen) 52
Lymphocytotoxic HLA antibodies and HB infection in transfused hemodialysis patients waiting for kidney transplantation 52
GA(2)LEN SKIN TEST STUDY I: GA(2)LEN HARMONIZATION OF SKIN PRICK TESTING: NOVEL SENSITIZATION PATTERNS FOR INHALANT ALLERGENS IN EUROPE 51
Recommendations for the standardization of clinical outcomes used in allergen immunotherapy trials for allergic rhinoconjunctivitis: an EAACI Position Paper. 51
Nerve growth factor (NGF): an important molecule for trophism and healing of the ocular surface 51
Prophylactic management of children at risk for recurrent upper respiratory infections: the Preventia I Study. 50
Reply 50
Rhinitis and asthma in athletes: an ARIA document in collaboration with GA2LEN 50
Integrated care pathways for airway diseases (AIRWAYS-ICPs). 49
Adult SURF Study Group. A survey of clinical features of allergic rhinitis in adults 49
Desloratadina: a new approach in the treatment of allergy as a systemic disease - pharmacology and clinical overview 49
Dampness in buildings as a risk factor for health effects, EUROEXPO: a multidisciplinary review of the literature (1998-2000) on dampness and mite exposure in buildings and health effects. 48
The eosinophil and the eye 48
Microbial products in allergy prevention and therapy 48
Nerve Growth Factor effect on human primary fibroblastic-keratocytes: possible mechanism during corneal healing 48
Efficacy of lodoxamide eye drops on mast cells and eosinophils after allergen challenge in allergic conjunctivitis 47
Nerve growth factor promotes corneal healing: structural, biochemical, and molecular analyses of rat and human corneas 47
Increased plasma levels of nerve growth factor in vernal keratoconjunctivitis 47
Severe Chronic Allergic (and Related) Diseases: A Uniform Approach - A MeDALL - GA(2)LEN - ARIA Position Paper. 46
Non specific provocation of target organs in allergic diseases 46
EXERCISE-INDUCED ASTHMA, RESPIRATORY AND ALLERGIC DISORDERS IN ELITE ATHLETES: EPIDEMIOLOGY, MECHANISMS AND DIAGNOSIS: PART I OF THE REPORT FROM THE JOINT TASK FORCE OF THE EUROPEAN RESPIRATORY SOCIETY (ERS) AND THE EUROPEAN ACADEMY OF ALLERGY AND CLINICAL IMMUNOLOGY (EAACI) IN COOPERATION WITH GA2LEN 46
Allergen extracts. Standardization of preparations for bronchial provocation tests. A position paper. (EAACI Sub-committee on Bronchial Provocation Tests) 46
Tear levels of neuropeptides increase after specific allergen challenge in allergic conjunctivitis. 46
Global Approach to the atopic Patient 45
Pooling birth cohorts in allergy and asthma: European Union-funded initiatives - a MeDALL, CHICOS, ENRIECO, and GA²LEN joint paper 44
GA(2)LEN SKIN TEST STUDY II: CLINICAL RELEVANCE OF INHALANT ALLERGEN SENSITIZATIONS IN EUROPE 44
Mechanisms of virus-induced asthma exacerbations: state-of-the-art. A GA(2)LEN and InterAirways document 44
Allergenic pollen and pollen allergy in Europe 44
The CONSORT statement checklist in allergen-specific immunotherapy: a GA2LEN paper 44
Reply to the letter of Dr. Feinberg in J Allergy Clin Immunol 1990; 85:141-2 44
WHO Intiative. Allergic Rhinitis and its Impact on Asthma (ARIA) 44
International consensus on allergy immunotherapy 44
Copyright. AQUE. Allergy Questionnaire for Exercisers 44
Practical approach to diagnosis and treatment of ocular allergy: a 1-year systematic review 43
GA2LEN SKIN TEST STUDY III: MINIMUM BATTERY OF TEST INHALENT ALLERGENS NEEDED IN EPIDEMIOLOGICAL STUDIES IN PATIENTS 43
Topical treatment with nerve growth factor for corneal neurotrophic ulcers 43
Allergen immunotherapy on the way to product-based evaluation - a WAO statement 43
Bridging allergologic and botanical knowledge in seasonal allergy, 42
Standard skin prick testing and sensitization to inhalant allergens across Europe – a survey from the GA2LEN network 42
What we should learn from the London Olympics. 42
Nerve Growth Factor and tissue repair remodeling : trkA (NGFR) and p75 (NTR) two receptors one fate. 42
[Phadiatop, a new in vitro method in the diagnosis and prevention of respiratory allergic diseases] 42
The relation between paracetamol use and asthma: a GA2LEN European case-control study 41
Effects of Salmeterol on Skeletal Muscle Cells: Metabolic and Pro-Apoptotic Features. 41
Which population level environmental factors are associated with asthma, rhinoconjunctivitis and eczema? Review of the ecological analyses of ISAAC Phase One 41
Allergy, asthma and markers of infections among Albanian migrants to Southern Italy. 41
Nerve Growth Factor has a modulatory role on human primary fibroblast coltures derived from vernal keratoconjunctivitis-affected conjunctiva 41
Increased serum levels of eosinophil cationic protein and eosinophil-derived neurotoxin (protein X) in vernal keratoconjunctivitis 41
Copyright. AQUA Allergy Questionnaire for Athletes 41
Primer di Allerghologia e Immunologia Clinica 41
First-in-human clinical trials - What we can learn from tragic failures 41
Building bridges for innovation in ageing: Synergies between Action Groups of the EIP on AHA 41
Markers of eosinophilic inflammation in allergic diseases 40
Allergic chronic inflammation of the ocular surface in vernal keratoconjunctivitis 40
Desloratadine: a new approach in the treatment of allergy as a systematic disease--pharmacology and clinical overview. Introduction 40
IgE serum levels in urinary schistosomiasis 40
Copyright. QUAQUA. Quality of life Questionnaire for Athletes 40
Intestinal permeability in patients with adverse reactions to food 39
Immunological profile of peripheral blood eosinophils in acute graft-vs-host disease 39
Increased plasma levels of substance P in vernal keratoconjunctivitis 39
Effects of topical pre-treatment with dexamethasone on the immediate and late phases of topically induced ocular anaphylaxis in the rat 39
Clinical trials in allergic conjunctivits: a systematic review. 39
T-helper 17 lymphocytes in ocular cicatricial pemphigoid 39
Allergic bronchial airway inflammation in Nerve Growth Factor (NGF) – derived rats: evidence suggesting a neuroimmunomodulatory role of NGF 39
Why is the incidence of asthma increasing? 39
Weight loss interventions in asthma: EAACI evidence-based clinical practice guideline (part I). 38
Protocolli Allergologici e Immunologici per la Gestione degli Atleti Agonisti e Non-Agonisti 38
CLOSE CORRELATION BETWEEN ANXIETY; DEPRESSION; AND ASTHMA CONTROL, 38
Airway inflammation in the elite athlete and type of sport 38
Evidence of non reproducibility. Human basophil histamine release is not triggered by very diluted anti-IgE. Letter 38
100 years of immunotherapy: the Monaco charter. under the high patronage of His Serene Highness Prince Albert II of Monaco. 38
An allergist is the new Executive Director of the European Medicine Agency.Editorial. 38
TLR4 and TLR9 Expression in Different Phenotypes of Rhinitis. 38
Allergen dose response and late symptoms in a human model of ocular allergy 38
Allergic conjunctivitis 37
Exercise-induced hypersensitivity syndromes in recreational and competitive athletes: a PRACTALL consensus report (what the general practitioner should know about sports and allergy) 37
Tear tryptase levels and allergic conjunctivitis 37
[New methods in allergology] 37
Epidemiology of rhinitis and conjunctivitis in athletes. 36
The role of shock organs in influencing the clinical expression of allergy 36
Flow cytometric evaluation of activated eosinophils in graft versus host disease and hypereosinophilic conditions 36
[Autoimmunity and lymphoproliferative diseases (proceedings)] 36
Manual of Clinical Trials in Allergy and Clinical Immunology 36
First-in-human clinical trials. What we can learn frm tragic failures. 36
Immunophenotypic profile of peripheral blood eosinophils in acute graft-vs.-host disease 35
Unmet needs in severe chronic upper airway disease (SCUAD) 35
Exercise-induced asthma and blood histamine 35
Totale 4.574
Salva come PNG Salva come JPEG
Categoria #
all - tutte 32.125
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 32.125
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/201936 0 0 0 0 0 0 0 0 0 8 17 11
2019/20201.223 248 251 5 6 244 15 261 10 139 17 20 7
2020/20211.814 226 0 259 60 269 4 254 245 0 281 181 35
2021/20221.233 173 1 2 14 492 3 20 38 46 4 94 346
2022/20232.186 251 3 8 169 190 179 1 146 1.151 12 43 33
2023/2024717 72 23 31 131 374 37 4 30 13 2 0 0
Totale 8.527